COVID-19, SARS-CoV-2, coronavirus, pandemic, antibodies, Iceland, qPCR, seroprevalence
COVID-19 Antibodies Last for at Least Four Months After Recovery
The results from a study in Iceland can’t say if a recovered patient’s antibodies can protect them from subsequent reinfection.
COVID-19 Antibodies Last for at Least Four Months After Recovery
COVID-19 Antibodies Last for at Least Four Months After Recovery

The results from a study in Iceland can’t say if a recovered patient’s antibodies can protect them from subsequent reinfection.

The results from a study in Iceland can’t say if a recovered patient’s antibodies can protect them from subsequent reinfection.

qPCR
COVID-19, SARS-CoV-2, pandemic, coronavirus, saliva, testing, PCR, FDA, emergency use authorization
FDA Approves New Saliva-Based COVID-19 Test
Amanda Heidt | Aug 17, 2020
SalivaDirect, an open-source protocol, avoids many of the supply bottlenecks of other tools and could be offered for as little as $10 a test.
COVID-19, coronavirus, SARS-CoV-2, pandemic, children, disease transmission, viral load, qPCR
Children Often Carry More Coronavirus than Adults Do: Study
Amanda Heidt | Jul 31, 2020
It’s not clear if their high viral load makes kids more likely to infect others.
COVID-19, SARS-CoV-2, pandemic, coronavirus, diagnostics, saliva, LAMP, PCR, clinical research, testing
Saliva Tests: How They Work and What They Bring to COVID-19
Amanda Heidt | Jul 9, 2020
Universities and healthcare facilities are planning to use spit tests to conduct large-scale screening.
Valerie Arboleda Uses Big Data to Unravel the Biology of a Rare Disease
Shawna Williams | May 1, 2018
The UCLA geneticist examines how defects in a histone protein lead to symptoms throughout the body.